Previous studies16,27 have shown that tamoxifen may increase the risk of venous thrombosis but has no significant effect or even a protective effect on arterial thrombosis (including coronary events), as it reduces coronary plaque in vivo, improves lipid levels, reduces C-reactive protein, and modulates nitric oxide production. Here, CRP is linked to Venous thrombosis.